German patients courted in medtech innovation drive
This article was originally published in Clinica
Patients in Germany can play a greater role in overcoming budgetary restraints that are preventing them from gaining access to innovative medical technologies. This was the conclusion arrived at last week in Berlin by medical experts at a seminar hosted by Aktion Meditech, a co-operative initiative between patient groups, healthcare experts, medical devices industry associations and companies.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.